Eye Popping Metrics! “SXP trades at a reasonable 3.5 times EV/ F23E EBITDA, which we believe could be fair for a declining envelope business but likely understates the value of packaging, with comparables trading at 7.5 times. As SXP continues its shift towards packaging, we expect a meaningful revaluation could occur.” ( Canaccord )
My Take: This story has been undercovered and misunderstood. New coverage is what the doctor ordered as it spreads the word. The analyst nails it!